PTPRC and neoplasm: Interestingly, robust HABN-Cy5.5 signal was detected in ~45% of CD45+CD11b+CD11c- TAMCs (p < 0.0001) and 20% of CD45- tumor cells (p < 0.05), whereas minimal HABN-Cy5.5 signal was detected among CD45+CD11b-CD11c- cells, CD45+CD11b-CD11c+ DCs, or CD45+CD11b-CD11c-Ly6G+ granulocytes (Fig. 1d).